Radiometer Proudly Sponsors 2023 World Sepsis Congress

The 4th World Sepsis Congress will be held virtually on April 25 and 26, 2023 with the theme of: One Global Health Threat: Sepsis, Pandemics, and Antimicrobial Resistance (AMR).

March 31, 2023

Congress attendees can hear from more than 85 interdisciplinary speakers who will discuss Sepsis from various perspectives. Topics will include the role of technology like AI, machine learning, big data; the link to pandemics and AMR; the latest research; policy impacts; and trial designs. This year’s focus is to show the interdependencies between Sepsis, pandemics and antimicrobial resistance.

The two-day Congress will include discussions on the impact of global health threats and tactics for addressing them, industry-driven research and highlights of regional initiatives aimed at addressing Sepsis care. The diverse range of this year’s speakers includes thought leaders, medical professionals, impacted patients and families and policy makers.

Since 2015, Radiometer is a proud supporter of the Global Sepsis Alliance, a non-profit organization of more than 100 organizations with the mission to provide global leadership, increase awareness, and reduce the worldwide burden of Sepsis. This year, Radiometer will sponsor the World Sepsis Congress, which covers 16 distinctive and highly relevant sessions:

Day 1

Session 1: Key Success Factors to Address Global Health Threats

Session 2: The Health Economic and Human Burden of Infections and Pandemics

Session 3: Overcoming Silos to Address Infection-Related Global Health Threats

Session 4: The Quality of Healthcare Systems and QI Efforts on Outcomes from Sepsis and Pandemics

Session 5: Advances and Challenges by Our Regional Sepsis Alliances

Session 6: Advances in Timely Pathogen and Sepsis Detection

Day 2

Session 7: The Benefits of Multidisciplinary Teams in Sepsis Care on the Health Care Facility Level

Session 8: The Potential and Challenges to Intervene with the Immune Response

Session 9: Biomarkers and Antimicrobial Stewardship – The Synergies to Diagnose Sepsis and to Prevent AMR

Session 10: Lessons from the Pandemic to Fight Common Infections and Sepsis

Session 11: Understanding and Improving Long-Term Outcomes After Sepsis and Covid-19

Session 12: Neonatal Sepsis Platforms and Guidelines

Session 13: The Impact of Survivors and Family Members to Improve Sepsis Awareness and Advocacy

Session 14: Maternal Sepsis: Why is it Still in the Top 3 for Global Incidence of Sepsis?

Session 15: Harnessing the Media to Advance the Global Fight Against Sepsis

Session 16: An Update on Research on Sepsis

Do you have colleagues who would be interested in attending? Please share the news and courage others to join. You can sign up and find more information here.

About Radiometer

Whatever comes next, we make sure life comes first.

Radiometer develops, manufactures, and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing, and related IT management systems. Today, Radiometer products and solutions are used in hospitals, clinics, and laboratories in over 130 countries, providing information on critical parameters in acute care diagnostics.

Through connected solutions, expert knowledge, and trusted partnership, we help health care professionals make diagnostic decisions to improve patient care.

Cookies are used on this website

Use of cookies

Don't show this message again

YES REQUEST ACCESS

Radiometer is using MICROSOFT AZURE AD to authenticate customer access. If you are already registered please click YES and you will be taken directly to the authentication portal to sign in using your MICROSOFT AD credentials. If you are unsure, please select REQUEST ACCESS and we will guide you through the sign-in process.

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

Allow the use of existing Active Directory credentials
Single-sign on experience
Use same credentials to access future services

Request access

You will receive an invitation to access our services via e-mail when your request has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.

Effective Date January 20th, 2023 (last updated January 20th, 2023)

ABOUT THIS POLICY

Radiometer values your privacy and the protection of your personal data. This policy (“Policy”) explains how Radiometer its affiliates, subsidiaries or related companies, a full list of which can be located here (together, “Radiometer”, “our”, “us”, or “we”), collects, uses, shares, transfers and processes data collected from or about you.

“Personal Data” is any information that can be used to directly or indirectly identify an individual or that can be reasonably expected to link to an individual. This can include items such as name, address, telephone number, credit card details, email address, ID number, Internet Protocol (“IP”) address of an electronic device used by an individual, or other identifying code (even absent of other identifying information). Statistical and non-identifiable metric data are not considered Personal Data.

The Radiometer subsidiary, affiliate or related company with which you interact is, where applicable, the data controller (or equivalent under applicable law) responsible for the processing of your Personal Data. You can find a list of the relevant legal entities that act as data controllers in Appendix 1 to this Policy.

SCOPE

This Policy describes the types of Personal Data that we may collect, process or disclose about you and how you may govern this processing by exercising applicable legal rights. This Policy applies to both online and offline information collection, including your use of websites or subdomains operated by us, any mobile applications, when we provide products and/or services to you or notify you about prospective items of interest and in other situations where you interact with us in-person, by telephone or by mail where this Policy is posted or referenced.

There may be occasion where you have been provided with a circumstance-specific privacy notice that is separate from this policy, such as privacy notices for specific activities such as Recruitment. To the extent you were provided with a different notice, those notices apply and govern our interactions with you. If you provide Personal Data about parties other than yourself, you are responsible for ensuring their knowledge of how we will process their personal data, and, where applicable, obtaining any necessary consents required in advance.

We are committed to processing Personal Data in accordance with applicable laws. Please note that if you do not wish to provide your Personal Data to us, some products and/or services may become unavailable to you. Your use of any or all these platforms indicates you have been notified of our collection, use, transfer, and disclosure of your information as described in this Policy to the extent permitted by applicable law.